Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours
Under normal physiological conditions, Fyn, a nonreceptor tyrosine kinase, is involved in signal transduction pathways in the nervous system and in the formation and activation of T lymphocytes. Fyn is a member of the Src family of kinases (SFKs) and plays a role in cell morphogenic transformation,...
Saved in:
| Main Authors: | Chongxi Xu, Yi Tang, Xing Lu, Ruiqi Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1485919/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Neuronal <i>Fyn</i> Knockdown in the Hippocampus in the Rat Kainate Model of Temporal Lobe Epilepsy
by: Nikhil S. Rao, et al.
Published: (2025-05-01) -
The underlying molecular mechanisms of Fyn in neonatal hypoxic-ischaemic encephalopathy
by: Jiao Zhou, et al.
Published: (2024-11-01) -
Editorial: Combination immunotherapy and immune response assessment of brain tumours
by: Haihui Jiang, et al.
Published: (2025-06-01) -
Retrospective analysis and comparison of immunohistochemical features of surgically treated primary-metastatic brain tumours
by: Sule Gokturk, et al.
Published: (2025-04-01) -
Canagliflozin alleviates acetaminophen-induced renal and hepatic injury in mice by modulating the p-GSK3β/Fyn-kinase/Nrf-2 and p-AMPK-α/STAT-3/SOCS-3 pathways
by: Abeer Bishr, et al.
Published: (2025-01-01)